Cargando…
Cefditoren in upper and lower community-acquired respiratory tract infections
This article reviews and updates published data on cefditoren in the evolving scenario of resistance among the most prevalent isolates from respiratory tract infections in the community (Streptococcus pyogenes, Haemophilus influenzae, and Streptococcus pneumoniae). By relating the in vitro activity...
Autores principales: | Soriano, Francisco, Giménez, María-José, Aguilar, Lorenzo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038999/ https://www.ncbi.nlm.nih.gov/pubmed/21340042 http://dx.doi.org/10.2147/DDDT.S9499 |
Ejemplares similares
-
Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
por: Giménez, María-José, et al.
Publicado: (2018) -
Update on the clinical utility and optimal use of cefditoren
por: Barberán, José, et al.
Publicado: (2012) -
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
por: Aguilar, Lorenzo, et al.
Publicado: (2010) -
Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007) -
LABORATORY DIAGNOSIS OF COMMUNITY-ACQUIRED LOWER RESPIRATORY TRACT INFECTION
por: Saubolle, Michael A., et al.
Publicado: (2001)